A multicenter, single arm phase II trial of a small molecule immune-modulator icaritin: Safety, overall survival, immune dynamics, and PD-L1 expression in advanced hepatocellular carcinoma.

2018 ◽  
Vol 36 (15_suppl) ◽  
pp. 4077-4077 ◽  
Author(s):  
Yan Sun ◽  
Qing Li ◽  
Jian-Ming Xu ◽  
Jun Liang ◽  
Ying Cheng ◽  
...  
Keyword(s):  
Hepatocellular Carcinoma ◽  
Overall Survival ◽  
Phase Ii ◽  
Small Molecule ◽  
Phase Ii Trial ◽  
Advanced Hepatocellular Carcinoma ◽  
Immune Modulator

Phase II trial of sorafenib in combination with 5-fluorouracil infusion in advanced hepatocellular carcinoma

2011 ◽  
Vol 69 (3) ◽  
pp. 773-780 ◽  
Author(s):  
Iacopo Petrini ◽  
Monica Lencioni ◽  
Miriam Ricasoli ◽  
Mauro Iannopollo ◽  
Cinzia Orlandini ◽  
...  
Keyword(s):  
Hepatocellular Carcinoma ◽  
Phase Ii ◽  
Phase Ii Trial ◽  
Advanced Hepatocellular Carcinoma

scholarly journals A phase II trial of gemcitabine in patients with advanced hepatocellular carcinoma

Cancer ◽  
2002 ◽  
Vol 94 (12) ◽  
pp. 3186-3191 ◽  
Author(s):  
Charles S. Fuchs ◽  
Jeffrey W. Clark ◽  
David P. Ryan ◽  
Mathew H. Kulke ◽  
Haesook Kim ◽  
...  
Keyword(s):  
Hepatocellular Carcinoma ◽  
Phase Ii ◽  
Phase Ii Trial ◽  
Advanced Hepatocellular Carcinoma

Phase II Trial of Docetaxel Therapy in Patients with Advanced Hepatocellular Carcinoma

Oncology ◽  
2006 ◽  
Vol 70 (2) ◽  
pp. 154-158 ◽  
Author(s):  
Mohamed Hebbar ◽  
Olivier Ernst ◽  
Stéphane Cattan ◽  
Sophie Dominguez ◽  
Corina Oprea ◽  
...  
Keyword(s):  
Hepatocellular Carcinoma ◽  
Phase Ii ◽  
Phase Ii Trial ◽  
Advanced Hepatocellular Carcinoma
Sign in / Sign up

Export Citation Format

Share Document